Source author record

Alexandra E. Porter

Alexandra E. Porter appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
4topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

An AI-driven framework for the prediction of personalised health response to air pollution

Air pollution is a growing global health threat, exacerbated by climate change and linked to cardiovascular and respiratory diseases. While personal sensing devices enable real-time physiological monitoring, their integration with environmental data for individualised health prediction remains underdeveloped. Here, we present a modular, cloud-based framework that predicts personalised physiological responses to pollution by combining wearable-derived data with real-time environmental exposures. At its core is an Adversarial Autoencoder (AAE), initially trained on high-resolution pollution-health data from the INHALE study and fine-tuned using smartwatch data via transfer learning to capture individual-specific patterns. Consistent with changes in pollution levels commonly observed in the real-world, simulated pollution spikes (+100%) revealed modest but measurable increases in vital signs (e.g., +2.5% heart rate, +3.5% breathing rate). To assess clinical relevance, we analysed U-BIOPRED data and found that individuals with such subclinical vital sign elevations had higher asthma burden scores or elevated Fractional Exhaled Nitric Oxide (FeNO), supporting the physiological validity of these AI-predicted responses. This integrative approach demonstrates the feasibility of anticipatory, personalised health modelling in response to environmental challenges, offering a scalable and secure infrastructure for AI-driven environmental health monitoring.

preprint2020arXiv

Label-Free Chemical Nano-Imaging of Intracellular Drug Binding Sites

Optical microscopy has a diffraction limited resolution of about 250 nm. Fluorescence methods (e.g. PALM, STORM, STED) beat this, but they are still limited to 10 s of nm, and the images are an indirect pointillist representation of only part of the original object. Here we describe a way of combining a sample preparation technique taken from histopathology, with a probe-based nano-imaging technique, (s SNOM) from the world of Solid State Physics. This allows us to image subcellular structures optically, and at a nanoscale resolution that is about 100 x better than normal microscopes. By adding a tuneable laser source, we also demonstrate mid-infrared chemical nano-imaging (MICHNI) in human myeloma cells and we use it to map the binding sites of the anti cancer drug bortezomib to less than 10 zL sized intracellular components. MICHNI is label free and can be used with any biological material and drugs with specific functional chemistry. We believe that its combination of speed, cheapness, simplicity, safety and chemical contrast promises a transformative impact across the life sciences.